STAT

Physicians’ beliefs may override cancer patients’ wishes for end-of-life care, study finds

Spending on cancer care in the last month of life varies widely across the U.S. A new study points to physician attitudes as a major reason.
Source: John Moore/Getty Images

Dr. Nancy Keating has seen what too much health care looks like. The Harvard Medical School professor recalls a patient with metastatic lung cancer who, despite not wanting chemotherapy, was convinced by her doctor to try a more targeted treatment. The patient spent the end of her life in the hospital – the exact place she had hoped to avoid.

Keating, also a physician at Brigham and Women’s Hospital, studies how to deliver high-quality care to patients with cancer. Her latest work examines the factors that contribute to large hospital-by-hospital differences in end-of-life spending for cancer patients. The new study reveals that the variation in the intensity of treatment stems more from the availability of services and physicians’ discomfort navigating end-of-life choices than from patients’ wishes.

From surveys,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related